Precigen (PGEN) prices public offering of 42.9M shares at $1.75, net ~$71.2M

PRECIGEN, INC.

Underwriting agreement with J.P. Morgan Securities as lead for 42,857,143 firm shares at $1.75/share.
Underwriters have 30-day option to purchase up to 6,428,571 additional shares.
Net proceeds of approximately $71.2 million after underwriting discount and expenses.
Offering made under existing shelf registration; use of proceeds for general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PRECIGEN, INC. entered into Underwriting Agreement with J.P. Morgan Securities LLC, as representative of the several underwriters named therein valued at approximately $71.2 million (effective 2023-01-24).

Action: entry
Agreement: underwriting
Counterparty: J.P. Morgan Securities LLC, as representative of the several underwriters named therein
Value: approximately $71.2 million
Effective: 2023-01-24

Exact text from the filing

On January 24, 2023, Precigen, Inc. (“Precigen”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, as representative of the several underwriters named therein (the “Underwriters”), in connection with the underwritten public offering (the "Offering") of 42,857,143 shares (the “Firm Shares”) of Precigen common stock, no par value (“Common Stock”), at a price to the public of $1.75 per share.

View on SEC.gov

23 material agreements filed in the last 30 days. Browse all material agreements →

PRECIGEN, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-007269

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.